Sexually transmitted diseases treatment guidelines, 2015.

Workowski KA, Bolan GA; Centers for Disease Control and Prevention. MMWR Recomm Rep. 2015 Jun 5;64(RR-03):1-137. PMID: 26042815 

Performance of Treponemal Tests for the Diagnosis of Syphilis.

Park IU, Fakile YF, Chow JM, Gustafson KJ, Jost H, Schapiro JM, Novak-Weekley S, Tran A, Nomura JH, Chen V, Beheshti M, Tsai T, Hoover K, Bolan G. Clin Infect Dis. 2019 Mar 5;68(6):913-918. doi: 10.1093/cid/ciy558. PMID: 29986091

Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.

Park IU, Introcaso C, Dunne EF. Clin Infect Dis. 2015 Dec 15;61 Suppl 8:S849-55. doi: 10.1093/cid/civ813. PMID: 26602622

Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis.

Lin C, Slama J, Gonzalez P, Goodman MT, Xia N, Kreimer AR, Wu T, Hessol NA, Shvetsov Y, Ortiz AP, Grinsztejn B, Moscicki AB, Heard I, Del Refugio González Losa M, Kojic EM, Schim van der Loeff MF, Wei F, Longatto-Filho A, Mbulawa ZA, Palefsky JM, Sohn AH, Hernandez BY, Robison K, Simpson S Jr, Conley LJ, de Pokomandy A, van der Sande MAB, Dube Mandishora RS, Volpini LPB, Pierangeli A, Romero B, Wilkin T, Franceschi S, Hidalgo-Tenorio C, Ramautarsing RA, Park IU, Tso FK, Godbole S, D'Hauwers KWM, Sehnal B, Menezes LJ, Heráclio SA, Clifford GM. Lancet Infect Dis. 2019 Aug;19(8):880-891. doi: 10.1016/S1473-3099(19)30164-1. Epub 2019 Jun 13. PMID: 31204304 

Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States - 2008-2012.

Hariri S, Bennett NM, Niccolai LM, Schafer S, Park IU, Bloch KC, Unger ER, Whitney E, Julian P, Scahill MW, Abdullah N, Levine D, Johnson ML, Steinau M, Markowitz LE; HPV-IMPACT Working Group. Vaccine. 2015 Mar 24;33(13):1608-13. doi: 10.1016/j.vaccine.2015.01.084. Epub 2015 Feb 11. PMID: 25681664

Estimated Number of Cases of High-Grade Cervical Lesions Diagnosed Among Women - United States, 2008 and 2016.

McClung NM, Gargano JW, Park IU, Whitney E, Abdullah N, Ehlers S, Bennett NM, Scahill M, Niccolai LM, Brackney M, Griffin MR, Pemmaraju M, Querec TD, Cleveland AA, Unger ER, Markowitz LE; HPV-IMPACT Working Group. MMWR Morb Mortal Wkly Rep. 2019 Apr 19;68(15):337-343. doi: 10.15585/mmwr.mm6815a1. PMID: 30998672

Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008-2014.

McClung NM, Gargano JW, Bennett NM, Niccolai LM, Abdullah N, Griffin MR, Park IU, Cleveland AA, Querec TD, Unger ER, Markowitz LE; HPV-IMPACT Working Group. Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):602-609. doi: 10.1158/1055-9965.EPI-18-0885. Epub 2019 Feb 21. PMID: 30792242

HPV and HPV-associated diseases.

Dunne EF, Park IU. Infect Dis Clin North Am. 2013 Dec;27(4):765-78. doi: 10.1016/j.idc.2013.09.001. PMID: 24275269 

Interventions to Improve Sexually Transmitted Disease Screening in Clinic-Based Settings.

Taylor MM, Frasure-Williams J, Burnett P, Park IU. Sex Transm Dis. 2016 Feb;43(2 Suppl 1):S28-41. doi: 10.1097/OLQ.0000000000000294. PMID: 26779685 

Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18.

Johnson Jones ML, Gargano JW, Powell M, Park IU, Niccolai LM, Bennett NM, Griffin MR, Querec T, Unger ER, Markowitz LE; HPV-IMPACT Working Group. Am J Epidemiol. 2020 Apr 2;189(4):265-276. doi: 10.1093/aje/kwz253. PMID: 31680146

Correlation of Treponemal Immunoassay Signal Strength Values with Reactivity of Confirmatory Treponemal Testing.

Fakile YF, Jost H, Hoover KW, Gustafson KJ, Novak-Weekley SM, Schapiro JM, Tran A, Chow JM, Park IU. J Clin Microbiol. 2017 Dec 26;56(1):e01165-17. doi: 10.1128/JCM.01165-17. Print 2018 Jan. PMID: 29046410 

Performance of the Syphilis Health Check in Clinic and Laboratory-Based Settings.

Fakile YF, Brinson M, Mobley V, Park IU, Gaynor AM. Sex Transm Dis. 2019 Apr;46(4):250-253. doi: 10.1097/OLQ.0000000000000974. PMID: 30628945

Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015.

Cleveland AA, Gargano JW, Park IU, Griffin MR, Niccolai LM, Powell M, Bennett NM, Saadeh K, Pemmaraju M, Higgins K, Ehlers S, Scahill M, Johnson Jones ML, Querec T, Markowitz LE, Unger ER; HPV-IMPACT Working Group. Int J Cancer. 2020 Feb 1;146(3):810-818. doi: 10.1002/ijc.32340. Epub 2019 May 6. PMID: 30980692

Trends in High-grade Cervical Lesions and Cervical Cancer Screening in 5 States, 2008-2015.

Gargano JW, Park IU, Griffin MR, Niccolai LM, Powell M, Bennett NM, Johnson Jones ML, Whitney E, Pemmaraju M, Brackney M, Abdullah N, Scahill M, Dahl RM, Cleveland AA, Unger ER, Markowitz LE; HPV-IMPACT Working Group. Clin Infect Dis. 2019 Apr 8;68(8):1282-1291. doi: 10.1093/cid/ciy707. PMID: 30137283

A systematic review of randomized trials assessing human papillomavirus testing in cervical cancer screening.

Patanwala IY, Bauer HM, Miyamoto J, Park IU, Huchko MJ, Smith-McCune KK. Am J Obstet Gynecol. 2013 May;208(5):343-53. doi: 10.1016/j.ajog.2012.11.013. Epub 2012 Nov 15. PMID: 23159693

Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006-2014: The impact of human papillomavirus vaccination.

Shing JZ, Hull PC, Zhu Y, Gargano JW, Markowitz LE, Cleveland AA, Pemmaraju M, Park IU, Whitney E, Mitchel EF, Griffin MR. Papillomavirus Res. 2019 Jun;7:141-149. doi: 10.1016/j.pvr.2019.04.007. Epub 2019 Apr 10. PMID: 30980966

Prevalence of human papillomavirus (HPV)-vaccine types by race/ethnicity and sociodemographic factors in women with high-grade cervical intraepithelial neoplasia (CIN2/3/AIS), Alameda County, California, United States.

Saadeh K, Park I, Gargano JW, Whitney E, Querec TD, Hurley L, Silverberg M. Vaccine. 2020 Jan 3;38(1):39-45. doi: 10.1016/j.vaccine.2019.09.103. Epub 2019 Oct 11. PMID: 31611099

A Case of Persistent and Possibly Treatment Resistant Pharyngeal Gonorrhea.

Levy V, Pandori M, Berrada ZL, Relucio KI, Lopez TP, Samuel MC, Park IU. Sex Transm Dis. 2016 Apr;43(4):258-9. doi: 10.1097/OLQ.0000000000000430. PMID: 26967304

Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008-2012.

Hariri S, Markowitz LE, Bennett NM, Niccolai LM, Schafer S, Bloch K, Park IU, Scahill MW, Julian P, Abdullah N, Levine D, Whitney E, Unger ER, Steinau M, Bauer HM, Meek J, Hadler J, Sosa L, Powell SE, Johnson ML; Hpv-Impact Working Group. Emerg Infect Dis. 2015 Sep;21(9):1557-61. doi: 10.3201/eid2109.141841. PMID: 26291379 

Discordant Syphilis Immunoassays in Pregnancy: Perinatal Outcomes and Implications for Clinical Management.

Mmeje O, Chow JM, Davidson L, Shieh J, Schapiro JM, Park IU. Clin Infect Dis. 2015 Oct 1;61(7):1049-53. doi: 10.1093/cid/civ445. Epub 2015 Jun 10. PMID: 26063719

Cytology and human papillomavirus co-test results preceding incident high-grade cervical intraepithelial neoplasia.

Park IU, Wojtal N, Silverberg MJ, Bauer HM, Hurley LB, Manos MM. PLoS One. 2015 Mar 20;10(3):e0118938. doi: 10.1371/journal.pone.0118938. eCollection 2015. PMID: 25793987

Race and ethnicity in trials of antihypertensive therapy to prevent cardiovascular outcomes: a systematic review.

Park IU, Taylor AL. Ann Fam Med. 2007 Sep-Oct;5(5):444-52. doi: 10.1370/afm.708. PMID: 17893387

Anal dysplasia in kidney transplant recipients.

Ogilvie JW Jr, Park IU, Downs LS, Anderson KE, Hansberger J, Madoff RD. J Am Coll Surg. 2008 Dec;207(6):914-21. doi: 10.1016/j.jamcollsurg.2008.08.005. Epub 2008 Sep 30. PMID: 19183539

Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States.

Hariri S, Johnson ML, Bennett NM, Bauer HM, Park IU, Schafer S, Niccolai LM, Unger ER, Markowitz LE; HPV-IMPACT Working Group. Cancer. 2015 Aug 15;121(16):2775-81. doi: 10.1002/cncr.29266. Epub 2015 Jun 22. PMID: 26098295

HPV type attribution in high-grade cervical lesions: assessing the potential benefits of vaccines in a population-based evaluation in the United States.

Hariri S, Unger ER, Schafer S, Niccolai LM, Park IU, Bloch KC, Bennett NM, Steinau M, Johnson ML, Markowitz LE; HPV-IMPACT Working Group. Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):393-9. doi: 10.1158/1055-9965.EPI-14-0649. Epub 2014 Nov 21. PMID: 25416715

Improvement of Sexually Transmitted Disease Screening Among HIV-Infected Men Who Have Sex With Men Through Implementation of a Standardized Sexual Risk Assessment Tool.

Scarborough AP, Slome S, Hurley LB, Park IU. Sex Transm Dis. 2015 Oct;42(10):595-8. doi: 10.1097/OLQ.0000000000000333. PMID: 26372932

Anal human papillomavirus infection and abnormal anal cytology in women with genital neoplasia.

Park IU, Ogilvie JW Jr, Anderson KE, Li ZZ, Darrah L, Madoff R, Downs L Jr. Gynecol Oncol. 2009 Sep;114(3):399-403. doi: 10.1016/j.ygyno.2009.05.008. Epub 2009 Jun 6. PMID: 19501896

Retesting for repeat chlamydial infection: family planning provider knowledge, attitudes, and practices.

Park IU, Amey A, Creegan L, Barandas A, Bauer HM. J Womens Health (Larchmt). 2010 Jun;19(6):1139-44. doi: 10.1089/jwh.2009.1648. PMID: 20482236

Screening for syphilis with the treponemal immunoassay: analysis of discordant serology results and implications for clinical management.

Park IU, Chow JM, Bolan G, Stanley M, Shieh J, Schapiro JM. J Infect Dis. 2011 Nov;204(9):1297-304. doi: 10.1093/infdis/jir524. Epub 2011 Sep 19. PMID: 21930610

Evaluation and Management of Anal Intraepithelial Neoplasia in HIV-Negative and HIV-Positive Men Who Have Sex with Men.

Park IU, Palefsky JM. Curr Infect Dis Rep. 2010 Mar;12(2):126-33. doi: 10.1007/s11908-010-0090-7. Epub 2010 Feb 24. PMID: 20461117

The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions.

Hariri S, Unger ER, Powell SE, Bauer HM, Bennett NM, Bloch KC, Niccolai LM, Schafer S, Markowitz LE; HPV-IMPACT Working Group. Cancer Causes Control. 2012 Feb;23(2):281-8. doi: 10.1007/s10552-011-9877-6. Epub 2011 Nov 23. PMID: 22108842

Cervical cancer prevention in the developing world.

Park IU, Diaz ML, Bowey C, Magaril R, Ferris DG; INCCA Foundation. J Low Genit Tract Dis. 2007 Oct;11(4):273. doi: 10.1097/LGT.0b013e31803399af. PMID: 17917572 

Initiating the American Society for Colposcopy and Cervical Pathology Humanitarian Program: Peru 2005.

Ferris DG, Park I, Waxman A, Joste N, Magaril RA, Greenspan D, Santos C, Galdos O, Velarde C, Bautista F, Salazar R, Tatti SA; 2005 ASCCP Humanitarian Group. J Low Genit Tract Dis. 2006 Jan;10(1):58-62. doi: 10.1097/01.lgt.0000192699.16044.57. PMID: 16378034

Patient-delivered partner therapy for chlamydial infections: practices, attitudes, and knowledge of california family planning providers.

Jotblad S, Park IU, Bauer HM, Barandas A, Deal M, Amey A. Sex Transm Dis. 2012 Feb;39(2):122-7. doi: 10.1097/OLQ.0b013e318237b723. PMID: 22249301

An assessment of the severity of recurrent appendicitis.

Dixon MR, Haukoos JS, Park IU, Oliak D, Kumar RR, Arnell TD, Stamos MJ. Am J Surg. 2003 Dec;186(6):718-22; discussion 722. doi: 10.1016/j.amjsurg.2003.08.016. PMID: 14672785